FDA Inspection 613021 — Hospira Worldwide, LLC
The FDA completed an inspection of Hospira Worldwide, LLC on Sep 18, 2009 in Pleasant Prairie, WI. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 18, 2009
- Fiscal Year
- 2009
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Pleasant Prairie, WI (United States)
Additional details
Postmarket Adverse Drug Experience (PADE)